Back to Results
First PageMeta Content
Mononegavirales / Tropical diseases / Zoonoses / Virology / Ebola virus disease / Zaire ebolavirus / Bundibugyo ebolavirus / Ebolavirus / Reston ebolavirus / Biology / Microbiology / Medicine


November 26, 2014 Dr. Sven Cramer Director, Regulatory Affairs altona Diagnostics GmbH Mörkenstraße 12
Add to Reading List

Open Document

File Size: 262,85 KB

Share Result on Facebook

Company

Diagnostics GmbH V. / Its Authorized Distributor(s) A. / N. CLIA High Complexity Laboratories / CLIA High Complexity Laboratories / O. CLIA High Complexity Laboratories / Diagnostics GmbH / M. CLIA High Complexity Laboratories / Laboratories L. CLIA High Complexity Laboratories / Similarly Qualified Non-U.S. Laboratories L. / Vitro Diagnostics / M.D. / /

Country

United States / Sudan / /

Event

Person Communication and Meetings / FDA Phase / /

IndustryTerm

federal law / investigational devices / mass media / manufacturing practice requirements / personal protective equipment / /

MedicalCondition

Ebola virus infection / Ebolavirus infection / disease / Ebola / Positive Control Target EBOLA / different Ebola / Ebola virus disease / infection / /

NaturalFeature

Tai Forest / /

Organization

U.S. Department of Health and Human Services / Food and Drug Administration / US Federal Reserve / Public Health Service / Department of Homeland Security / /

Person

Michael Chertoff / Sven Cramer / Margaret A. Hamburg / /

Position

Director / Regulatory Affairs / Commissioner / Secretary / HHS Secretary / /

Product

RealStar® Ebolavirus RT / /

Region

West Africa / /

Technology

in vitro diagnostics / /

URL

http /

SocialTag